Medite Cancer Diagnostics, Inc. — US58503D3098
Source record · Medite Cancer Diagnostics, Inc. — US58503D3098
- ISIN
- US58503D3098
- Issuer LEI
- 5493004TQCU6VE3HL796
- Issuer
- Medite Cancer Diagnostics, Inc.
- Prefix
- US
- Country
- United States
- National code
- 58503D309
- Check digit
- 8 (verifies)
- CUSIP
- 58503D309
- Handle
- #://US58503D3098
- Edition address
- web+usd://isin-us58503d3098
- GTIN
- 29780106303742
Source · https://mapping.gleif.org/api/v2/isin-lei?page%5Bnumber%5D=1&page%5Bsize%5D=1
Retrieved · 2026-10-18T06:45:16.388Z
ISIN US58503D3098 edition: identity from GLEIF/ANNA (CC0); no valuation or affiliation implied. CUSIP 58503D309 is derived from the ISIN itself.